An international team of researchers has discovered saarvienin A, a new type of glycopeptide antibiotic. Their findings introduce a compound with strong activity against highly resistant bacterial ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

A recent study published in the journal Microbiome has uncovered an interesting discovery in NASA’s cleanrooms: new species ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

[Photo provided to chinadaily.com.cn] Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma ... and the investment community to engage in in-depth discussions on the latest ...

Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.

Grit Biotechnology Co., Ltd. ('Grit Bio'), a clinical-stage biotech pioneering novel immunotherapies announced today that three research programs, in collaboration with Vitalgen BioPharma Co., Ltd.

Princeton Engineering Innovation Research Grants support bold new ideas tackling critical problems like antibiotic resistance ...

Bioheaven360 introduces AI-driven genomics diagnostic platform for early disease detection: Our Bureau, Bengaluru Thursday, May 8, 2025, 14:15 Hrs [IST] Bioheaven360 Genotec, a le ...

Bio-Techne surpasses profit expectations with significant growth in its research products, leading to the announcement of a ...

Discover how a flexible protein can rearrange itself to multitask efficiently, revolutionizing medicine, agriculture, and ...

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...